Literature DB >> 33479401

Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.

Atala B Jena1, Namrata Kanungo2, Vinayak Nayak2, G B N Chainy2, Jagneshwar Dandapat3,4.   

Abstract

The recent outbreak of the coronavirus (SARS-CoV2) is an unprecedented threat to human health and society across the globe. In this context, development of suitable interventions is the need of the hour. The viral spike protein (S Protein) and the cognate host cell receptor ACE2 can be considered as effective and appropriate targets for interventions. It is evident from the present computational study, that catechin and curcumin, not only exhibit strong binding affinity to viral S Protein and host receptor ACE2 but also to their complex (receptor-binding domain (RBD) of the spike protein of SARS-CoV2 and ACE2; RBD/ACE2-complex). The binding affinity values of catechin and curcumin for the S protein, ACE2 and RBD/ACE2-complex are - 10.5 and - 7.9 kcal/mol; - 8.9 and - 7.8 kcal/mol; and - 9.1 and - 7.6 kcal/mol, respectively. Curcumin directly binds to the receptor binding domain (RBD) of viral S Protein. Molecular simulation study over a period of 100 ns further substantiates that such interaction within RBD site of S Protein occurs during 40-100 ns out of 100 ns simulation trajectory. Contrary to this, catechin binds with amino acid residues present near the RBD site of S Protein and causes fluctuation in the amino acid residues of the RBD and its near proximity. Both catechin and curcumin bind the interface of 'RBD/ACE2-complex' and intervene in causing fluctuation of the alpha helices and beta-strands of the protein complex. Protein-protein interaction studies in presence of curcumin or catechin also corroborate the above findings suggesting the efficacy of these two polyphenols in hindering the formation of S Protein-ACE2 complex. In conclusion, this computational study for the first time predicts the possibility of above two polyphenols for therapeutic strategy against SARS-CoV2.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33479401      PMCID: PMC7820253          DOI: 10.1038/s41598-021-81462-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  22 in total

1.  The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.

Authors:  Christopher Weber; Katja Sliva; Christine von Rhein; Beate M Kümmerer; Barbara S Schnierle
Journal:  Antiviral Res       Date:  2014-11-11       Impact factor: 5.970

Review 2.  Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.

Authors:  J Steinmann; J Buer; T Pietschmann; E Steinmann
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

3.  The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.

Authors:  Berend Jan Bosch; Ruurd van der Zee; Cornelis A M de Haan; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 4.  Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis.

Authors:  Jean Kaoru Millet; Gary R Whittaker
Journal:  Virus Res       Date:  2014-11-22       Impact factor: 3.303

5.  Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.

Authors:  Xing-Yi Ge; Jia-Lu Li; Xing-Lou Yang; Aleksei A Chmura; Guangjian Zhu; Jonathan H Epstein; Jonna K Mazet; Ben Hu; Wei Zhang; Cheng Peng; Yu-Ji Zhang; Chu-Ming Luo; Bing Tan; Ning Wang; Yan Zhu; Gary Crameri; Shu-Yi Zhang; Lin-Fa Wang; Peter Daszak; Zheng-Li Shi
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

6.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  Prediction of functional loss of human angiogenin mutants associated with ALS by molecular dynamics simulations.

Authors:  Aditya K Padhi; Bhyravabhotla Jayaram; James Gomes
Journal:  Sci Rep       Date:  2013-02-07       Impact factor: 4.379

9.  Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales.

Authors:  Wanjun Gu; Tong Zhou; Jianmin Ma; Xiao Sun; Zuhong Lu
Journal:  Virus Res       Date:  2004-05       Impact factor: 3.303

View more
  34 in total

1.  Multiplex Testing of Oxidative-Reductive Pathway in Patients with COVID-19.

Authors:  Paul C Guest; Mitra Abbasifard; Tannaz Jamialahmadi; Muhammed Majeed; Prashant Kesharwani; Amirhossein Sahebkar
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Chemistry of Protein-Phenolic Interactions Toward the Microbiota and Microbial Infections.

Authors:  Hilal Yilmaz; Busra Gultekin Subasi; Hasan Ufuk Celebioglu; Tugba Ozdal; Esra Capanoglu
Journal:  Front Nutr       Date:  2022-07-01

Review 3.  Novel and Controversial Therapies in COVID-19.

Authors:  Romil Singh; Likhita Shaik; Ishita Mehra; Rahul Kashyap; Salim Surani
Journal:  Open Respir Med J       Date:  2020-12-31

4.  Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity.

Authors:  Sugandh Kumar; Bharati Singh; Pratima Kumari; Preethy V Kumar; Geetanjali Agnihotri; Shaheerah Khan; Tushar Kant Beuria; Gulam Hussain Syed; Anshuman Dixit
Journal:  Comput Struct Biotechnol J       Date:  2021-04-07       Impact factor: 7.271

Review 5.  Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review.

Authors:  Jeffersson Krishan Trigo-Gutierrez; Yuliana Vega-Chacón; Amanda Brandão Soares; Ewerton Garcia de Oliveira Mima
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

6.  Scrutinizing the Feasibility of Nonionic Surfactants to Form Isotropic Bicelles of Curcumin: a Potential Antiviral Candidate Against COVID-19.

Authors:  Dina B Mahmoud; Mohamed Mofreh Bakr; Ahmed A Al-Karmalawy; Yassmin Moatasim; Ahmed El Taweel; Ahmed Mostafa
Journal:  AAPS PharmSciTech       Date:  2021-12-29       Impact factor: 3.246

Review 7.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 8.  Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.

Authors:  Arumugam Vijaya Anand; Balasubramanian Balamuralikrishnan; Mohandass Kaviya; Kathirvel Bharathi; Aluru Parithathvi; Meyyazhagan Arun; Nachiappan Senthilkumar; Shanmugam Velayuthaprabhu; Muthukrishnan Saradhadevi; Naif Abdullah Al-Dhabi; Mariadhas Valan Arasu; Mohammad Iqbal Yatoo; Ruchi Tiwari; Kuldeep Dhama
Journal:  Molecules       Date:  2021-03-22       Impact factor: 4.411

9.  Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions.

Authors:  Anna Goc; Waldemar Sumera; Matthias Rath; Aleksandra Niedzwiecki
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

Review 10.  Does Oxidative Stress Management Help Alleviation of COVID-19 Symptoms in Patients Experiencing Diabetes?

Authors:  Alok K Paul; Md K Hossain; Tooba Mahboob; Veeranoot Nissapatorn; Polrat Wilairatana; Rownak Jahan; Khoshnur Jannat; Tohmina A Bondhon; Anamul Hasan; Maria de Lourdes Pereira; Mohammed Rahmatullah
Journal:  Nutrients       Date:  2022-01-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.